Increased expression of LAMC2 has been evaluated in a variety of cancers, including esophageal, colorectal, gastric, oral squamous cell, and prostate cancers, and it has also been associated with invasiveness in cervical lesions [28] and KRT17 in oral cancer [29]. This evidence concerns the gene LAMC2 and prostate carcinoma.